| Cathleen M Czaplewski, | |
|
1049 East Wilson Street, Suite 100, Batavia, IL 60510 | |
| (630) 761-0900 | |
| (630) 761-0909 |
| Full Name | Cathleen M Czaplewski |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1049 East Wilson Street, Batavia, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003970138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cathleen M Czaplewski, 1049 East Wilson Street, Suite 100, Batavia, IL 60510 Ph: (630) 761-0900 | Cathleen M Czaplewski, 1049 East Wilson Street, Suite 100, Batavia, IL 60510 Ph: (630) 761-0900 |
News Archive
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and rare genetic metabolic disorders, today announced the first data from the dose-escalation portion of the ongoing Phase 1 study evaluating single agent AG-120, a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-1 (IDH1), in advanced solid tumors. The data are being presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston. AG-120 is being developed in collaboration with Celgene.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced positive preliminary results of a Phase IIa study in inflammatory bowel disease (IBD) with its lead autoimmune compound vidofludimus, an oral inhibitor of interleukin-17 (IL-17) release.
City of Hope surgical researchers are the first in the nation to open a clinical trial that could one day become an effective way to deliver chemotherapy to abdominal cancer patients who currently have very few treatment options.
Bioinformaticians at IMIM (Hospital del Mar Medical Research Institute) and UPF (Pompeu Fabra University) have used molecular simulation techniques to explain a specific step in the maturation of the HIV virions, i.e., how newly formed inert virus particles become infectious, which is essential in understanding how the virus replicates.
› Verified 4 days ago
Courtney Hayes, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 366 Mill St, Batavia, IL 60510 Phone: 630-220-0611 | |
Jennifer L Vilt, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1049 East Wilson Street, Suite 100, Batavia, IL 60510 Phone: 630-761-0900 Fax: 630-761-0909 | |
Kelly Ryan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 E Wilson St Ste 100, Batavia, IL 60510 Phone: 630-761-0900 | |
Mr. Joseph Robert Sierra Iii, M.H.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1049 E Wilson St, #100, Batavia, IL 60510 Phone: 630-761-0900 | |
Marcia Lynn Swinarski, MS CCC SLP L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1049 East Wilson Street, Suite 100, Batavia, IL 60510 Phone: 630-761-0900 Fax: 630-761-0909 | |
Ms. Maria Terese Oliva, MS SPEECH LANG PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1049 East Wilson Street, Suite 100, Batavia, IL 60510 Phone: 630-761-0900 Fax: 630-761-0909 |